SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jacques Chitte who wrote (3498)4/20/1998 9:43:00 PM
From: Linda Kaplan  Read Replies (1) of 7041
 
If Vasomax doesn't WORK, then the stock will also become worthless eventually. I don't think the Street's enthusiasm for sexy drugs will last through that. Even if FDA approves Vasomax, and I think that's unlikely, people will buy Vasomax once and won't refill if it doesn't work, and that will be that. A lot of play is being given to the recreational use of Viagra and the fact women are using it, too. CNBC has been touting it, constantly, saying that people are using it less for medical than for recreational purposes and that it just increases blood flow.

There's some overflow to Muse, because Muse works on some populations that can't be helped by Viagra. But if Vasomax doesn't work, that will be the end of Zonagen.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News